Gastrointestinal disorders: Common: Rather loose stools or diarrhoea were observed in clinical studies during the therapy.
Very rare: Severe right upper abdominal pain (in patients with primary biliary cirrhosis).
Hepatobiliary disorders: Very rare: Calcification of gallstones, decompensation of liver cirrhosis (in patients with primary biliary cirrhosis in an advanced stage), which partially subsided after the treatment was discontinued.
Skin and subcutaneous tissue disorders: Very rare: Urticaria (mainly at the beginning of the therapy).
View ADR Reporting Link